Details for Patent: 8,206,740
✉ Email this page to a colleague
Which drugs does patent 8,206,740 protect, and when does it expire?
Patent 8,206,740 protects ORACEA and is included in one NDA.
This patent has eighteen patent family members in eight countries.
Summary for Patent: 8,206,740
| Title: | Once daily formulations of tetracyclines |
| Abstract: | Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, and acute and chronic inflammatory disease states, such as rosacea and arthritis. |
| Inventor(s): | Chang; Rong-Kun (Rockville, MD), Raoufinia; Arash (Springfield, VA), Shah; Niraj (Owings Mills, MD) |
| Assignee: | Supernus Pharmaceuticals, Inc. (Rockville, MD) |
| Application Number: | 12/155,676 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,206,740 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; Formulation; Use; Process; |
More… ↓ |
Drugs Protected by US Patent 8,206,740
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | ORACEA | doxycycline | CAPSULE;ORAL | 050805-001 | May 26, 2006 | AB | RX | Yes | Yes | 8,206,740 | ⤷ Subscribe | Y | TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTULES) OF ROSACEA | ⤷ Subscribe | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,206,740
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2521885 | ⤷ Subscribe | |||
| Canada | 2803922 | ⤷ Subscribe | |||
| Canada | 2894736 | ⤷ Subscribe | |||
| Denmark | 1615622 | ⤷ Subscribe | |||
| Denmark | 2204168 | ⤷ Subscribe | |||
| European Patent Office | 1615622 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
